Hong Kong at a glance
- Population
- 7.5 million 2025
- Life expectancy at birth
- 85.4 years, 2024
- People aged 65 and over
- 23.7 % of people, 2025
Updated
Reviewed by Chandani Patel
Hong Kong Whole Genome Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$23.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $5.2 Mn | — | — |
| 2025 (base) | $6.2 Mn | +$1.0 Mn | — |
| 2026 (forecast) | $7.4 Mn | +$1.2 Mn | +19.1% |
| 2027 (forecast) | $8.9 Mn | +$1.4 Mn | +41.8% |
| 2028 (forecast) | $10.5 Mn | +$1.7 Mn | +68.9% |
| 2029 (forecast) | $12.6 Mn | +$2.0 Mn | +101.2% |
| 2030 (forecast) | $15.0 Mn | +$2.4 Mn | +139.6% |
| 2031 (forecast) | $17.8 Mn | +$2.9 Mn | +185.4% |
| 2032 (forecast) | $21.2 Mn | +$3.4 Mn | +239.9% |
| 2033 (forecast) | $25.3 Mn | +$4.1 Mn | +304.8% |
| 2034 (forecast) | $30.1 Mn | +$4.8 Mn | +382.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $6.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $30.1 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 19.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Illumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences (see all) |
| Regulator in Hong Kong | Drug OfficeSource: Drug Office, Department of Health. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Whole genome sequencing reads a person's entire DNA code, used for rare disease diagnosis, cancer, research and population health.
Key segments of the whole Genome Sequencing market include product (Instruments, Consumables and Services) and application (Rare Disease Diagnosis, Oncology and Population Genomics).
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.
Routine use of genomics in screening, pharmacy and primary care gives the whole Genome Sequencing market large room to grow.
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the whole Genome Sequencing market.
The whole Genome Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.[2]
[1] Drug Office, Department of Health. Checked 14 Nov 2026.
[2] Hospital Authority. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for whole Genome Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Hong Kong.
What doctors and scientists are doing in Whole Genome Sequencing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
Hong Kong · 3 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 1 shared keyword
Digital Health · Hong Kong
Healthcare Services · Hong Kong
Healthcare Services · Hong Kong
Medical Devices · Hong Kong
Digital Health · Hong Kong
Medical Devices · Hong Kong